Gene Therapy in Treating Patients With Advanced Head and Neck Cancer
Status:
Completed
Trial end date:
2002-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Gene therapy may kill cancer cells by inhibiting a gene that promotes the
development and growth of cancer.
PURPOSE: Phase I trial to study the effectiveness of gene therapy in treating patients who
have advanced head and neck cancer.